People taking Novo Nordisks Wegovy experienced reduced food noise and boosted mental well-being
Results from a real-world survey suggest that semaglutide for weight management (Wegovy®)…
Eightco Holdings Inc. Announces Nasdaq Ticker Symbol Change to ORBS, Advancing the AI Revolution
Dan Ives, renowned technology and AI expert and Wall Street analyst, to…
Three global institutions win million dollar prize for the 2025 Antnio Champalimaud Vision Award
Valued at €1 million, it is the world's largest award in the…
Startek Philippines earns Great Place to Work Certification for the third consecutive year
MUMBAI, India, Sept. 9, 2025 /PRNewswire/ -- Startek®, a digital-first global customer…
GSMA calls for renewed focus on closing the Usage Gap as more than 3 billion people remain offline despite available mobile internet services
LONDON, Sept. 9, 2025 /PRNewswire/ -- 4.7 billion people, or 58% of…
Four initiatives funded by the Olympic Refuge Foundation tackle inclusion and hate
04 September 2025 – Four projects have each been awarded USD 50,000…
/C O R R E C T I O N — Public Interest Registry/
Public Interest Registry Announces 2025 .ORG Impact Awards Finalists, Artist & Actor…
Humbirdy Launches AI Bird Feeder 4K Ultra: Turning Backyards into Personal Nature Documentaries
New York, NY, Sept. 01, 2025 (GLOBE NEWSWIRE) -- For most people,…
Best Ally in the fight against corruption
HONG KONG, Aug. 28, 2025 /PRNewswire/ -- "Hong Kong, our advantage is…
Novo Nordisks Wegovy cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular diseas
Compared with tirzepatide, Wegovy® (semaglutide 2.4 mg) showed a significant 57% greater…